Natsuko Inoue

Nishinomiya-hama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

IL-18 primes T cells with an antigen-inexperienced memory phenotype for proliferation and differentiation into effector cells through Notch signaling.

IL-18 primes T cells with an antigen-inexperienced memory phenotype for proliferation and differentiation into effector cells through Notch signaling.

Journal: Journal of leukocyte biology

Published: July 05, 2024

Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer Subtypes.

Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer Subtypes.

Journal: Anticancer research

Published: February 03, 2020

High Serum Levels of Interleukin-18 Are Associated With Worse Outcomes in Patients With Breast Cancer.

High Serum Levels of Interleukin-18 Are Associated With Worse Outcomes in Patients With Breast Cancer.

Journal: Anticancer research

Published: June 28, 2019

Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancer.

Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancer.

Journal: Cancer science

Published: June 19, 2019

Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.

Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.

Journal: The Journal of clinical investigation

Published: April 17, 2018

Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.

Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.

Journal: Breast cancer research and treatment

Published: August 22, 2017

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.

Journal: PloS one

Published: March 28, 2017

Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.

Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.

Journal: Clinical breast cancer

Published: September 29, 2014

Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.

Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.

Journal: Breast cancer (Tokyo, Japan)

Published: March 03, 2014

C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis.

C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis.

Journal: Breast cancer (Tokyo, Japan)

Published: April 25, 2013

Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers.

Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers.

Journal: Breast cancer (Tokyo, Japan)

Published: November 10, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026